Clinical Trials Browser

Phase 3 × Hepatitis B × Tenofovir × Clear all

NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

Phase 3 Terminated

4 enrolled 5 charts

Hepatitis B

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

Phase 3 Unknown

Hepatitis B, Lymphoma

NCT01872988 2014-09-04

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Phase 3 Terminated

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic